Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, Macau, India, Malaysia, Indonesia, Myanmar, Vietnam, the Philippines, Bangladesh, and internationally. More Details
+ 1 more risk
Undervalued with excellent balance sheet.
Share Price & News
How has Cordlife Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 3DC is more volatile than 90% of German stocks over the past 3 months, typically moving +/- 13% a week.
Volatility Over Time: 3DC's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of German stocks.
7 Day Return
1 Year Return
Return vs Industry: 3DC exceeded the German Healthcare industry which returned 0.6% over the past year.
Return vs Market: 3DC underperformed the German Market which returned 42.4% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Cordlife Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is Cordlife Group undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: 3DC (€0.22) is trading below our estimate of fair value (€1.54)
Significantly Below Fair Value: 3DC is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: 3DC is good value based on its PE Ratio (14.2x) compared to the DE Healthcare industry average (32.5x).
PE vs Market: 3DC is good value based on its PE Ratio (14.2x) compared to the German market (28.2x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 3DC's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 3DC is good value based on its PB Ratio (0.7x) compared to the DE Healthcare industry average (1.7x).
How is Cordlife Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Cordlife Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Cordlife Group performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 3DC has a large one-off gain of SGD2.4M impacting its December 31 2020 financial results.
Growing Profit Margin: 3DC's current net profit margins (12.9%) are higher than last year (10.5%).
Past Earnings Growth Analysis
Earnings Trend: 3DC's earnings have declined by 34.6% per year over the past 5 years.
Accelerating Growth: 3DC's earnings growth over the past year (1.1%) exceeds its 5-year average (-34.6% per year).
Earnings vs Industry: 3DC earnings growth over the past year (1.1%) underperformed the Healthcare industry 2%.
Return on Equity
High ROE: 3DC's Return on Equity (4.9%) is considered low.
How is Cordlife Group's financial position?
Financial Position Analysis
Short Term Liabilities: 3DC's short term assets (SGD100.4M) exceed its short term liabilities (SGD26.4M).
Long Term Liabilities: 3DC's short term assets (SGD100.4M) exceed its long term liabilities (SGD73.8M).
Debt to Equity History and Analysis
Debt Level: 3DC's debt to equity ratio (3%) is considered satisfactory.
Reducing Debt: 3DC's debt to equity ratio has reduced from 65% to 3% over the past 5 years.
Debt Coverage: 3DC's debt is well covered by operating cash flow (398.7%).
Interest Coverage: Insufficient data to determine if 3DC's interest payments on its debt are well covered by EBIT.
What is Cordlife Group current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 3DC's dividend (2.47%) is higher than the bottom 25% of dividend payers in the German market (1.06%).
High Dividend: 3DC's dividend (2.47%) is low compared to the top 25% of dividend payers in the German market (3.21%).
Stability and Growth of Payments
Stable Dividend: 3DC has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 3DC has only been paying a dividend for 9 years, and since then payments have fallen.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (35%), 3DC's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Poh Lan Tan (58 yo)
Ms. Poh Lan Tan has been Group Chief Executive Officer and Executive Director at Cordlife Group Limited since February 28, 2019 and served as its Group Chief Operating Officer since April 12, 2016 until 20...
Experienced Management: 3DC's management team is considered experienced (4.2 years average tenure).
Experienced Board: 3DC's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Cordlife Group Limited's company bio, employee growth, exchange listings and data sources
- Name: Cordlife Group Limited
- Ticker: 3DC
- Exchange: BST
- Founded: 2001
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: S$92.923m
- Listing Market Cap: S$58.036m
- Shares outstanding: 254.58m
- Website: https://www.cordlife.com
- Cordlife Group Limited
- A’Posh Bizhub
- No. 06-01/09, 1 Yishun Ind. St 1
Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, Macau, India, Malaysia, Indonesia, Myanmar, Vietnam, the Philippines, Bangladesh, and in...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/04/14 21:32|
|End of Day Share Price||2021/04/14 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.